Sign up to save your podcasts
Or
Share Pembrolizumab, Tumor Response, and Survival in Advanced Melanoma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Pembrolizumab, Tumor Response, and Survival in Advanced Melanoma
Interview with Antoni Ribas, MD, PhD, author of Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
View all episodes
By JAMA Network
4.6
162162 ratings
Interview with Antoni Ribas, MD, PhD, author of Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
More shows like JAMA Author Interviews
View all
JAMA Editors' Summary
130 Listeners
NEJM This Week
319 Listeners
This Week in Cardiology
858 Listeners
JAMA Clinical Reviews
487 Listeners
AFP: American Family Physician Podcast
686 Listeners
Mayo Clinic Talks
275 Listeners
Frankly Speaking About Family Medicine
252 Listeners
The Curbsiders Internal Medicine Podcast
3,325 Listeners
JAMA Dermatology Author Interviews
17 Listeners
JAMA Internal Medicine Author Interviews
18 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Psychiatry Author Interviews
23 Listeners
JAMA Medical News
85 Listeners
Core IM | Internal Medicine Podcast
1,094 Listeners
JAMAevidence The Rational Clinical Examination
29 Listeners
Annals On Call Podcast
181 Listeners
The Clinical Problem Solvers
509 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
321 Listeners
Run the List
242 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
19 Listeners
The Curious Clinicians
361 Listeners